Research Methodology – PD-1 And PDL-1 Inhibitor Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the PD-1 And PDL-1 Inhibitor Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the PD-1 And PDL-1 Inhibitor Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors to Consider While Calculating Market Size and Share
- Current patient population diagnosed with cancer diseases globally.
- Total economic burden of treating cancer diseases without PD-1 and PDL-1 inhibitors.
- Prevalence and incidence rates of specific cancers where PD-1 and PDL-1 inhibitors are highly applicable.
- The number of companies manufacturing PD-1 and PDL-1 inhibitors, their production capacities and individual market shares.
- Adoption rate of PD-1 and PDL-1 inhibitors in the medical community.
- Prices of PD-1 and PDL-1 inhibitors versus other traditional cancer therapies.
- Market penetration in developing economies.
- Existing regulations and policies guiding the production, distribution, and use of PD-1 and PDL-1 inhibitors.
Key Market Indicators
- Growth rate of new cancer diagnosis globally.
- Change in revenue generation from the sales of PD-1 and PDL-1 inhibitors.
- Trends in healthcare spending on oncology medicine.
- Rate of technological advancements in cancer treatment methodologies.
- Changes in demographics that increase the risk of cancer diseases (ageing population, lifestyle trends, etc.).
- Studies and reports on efficacy and safety of PD-1 and PDL-1 inhibitors.
Growth Trends
- Increase in global health care spending on oncology medicine.
- Increasing adoption of targeted therapy in cancer treatment.
- Increased understanding and awareness of the benefits of immunotherapy in cancer treatment.
- Growth in the number of FDA approvals for new PD-1 and PDL-1 inhibitors.
- Rapid development in personalized medicine leading to increased usage of PD-1 and PDL-1 inhibitors.
- Innovation and technological advancements in the production of PD-1 and PDL-1 inhibitors.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the PD-1 And PDL-1 Inhibitor Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the PD-1 And PDL-1 Inhibitor Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Our Clients:
